Skip to main content
. 2019 Mar 21;14(3):e0212193. doi: 10.1371/journal.pone.0212193

Table 1. Characteristics of the study population.

Variable ME/CFS (n = 14) Control (n = 11) P Value
Age in years, median (IQR) 49 (38, 58.3) 50 (45.5, 58.5) 0.6216
BMI, median (IQR) 26.63 (21.4, 34.9) 26.45 (24.1, 35.2) 0.7675
Core Symptoms, n (%)
Fatigue 14 (100) 1 (9) < .00001
Pain 14 (100) 3 (27) < .001
Post Exertional Fatigue 14 (100) 1 (9) < .00001
Karnofsky Score Last 7 Days 60 (56.25, 68.75) 100 (90, 100) < .0001
Functional Capacity Last 7 Days 4 (3, 5.75) 8 (7.75, 8) < .0001
Illness Onset Pattern n (%)
Gradual 9 (64) NA NA
Sudden 5 (36) NA NA
History of Infection at Onset 9 (64) NA NA
Illness duration yrs, median (IQR) 5.75 (5, 7.5) NA NA
Baseline 5 Day Accelerometry, Median(IQR)
Wear Time (% of time) 90.5 (89, 94) 95 (93, 96) 0.1958
Steps in 5 Days 28447(15722,33186) 32995 (20940,50688) 0.2671
Activity Distribution (% of time)
Sedentary 78.4 (71,81.5) 74.5 (71.1,77.2) 0.3111
Light 21.05 (18,26) 22.8 (20.5,24.6) 0.5719
Moderate 1.1 (0.3,2.1) 1.3 (0.8,4.2) 0.2612
Vigorous 0.0 (0, 0) 0.0 (0, 0) 0.8084
Sleeping (Hours of Sleep Per 24 Hours) 6.7 (5.9, 7.9) 7.3 (6.2, 7.9) 0.4593
Awakenings (Per 24 Hours) 5.8 (4.6,6.9) 8.2 (5.3, 10) 0.0708

Values are presented as median (IQR). P values were calculated with Wilcoxon rank-sum test. Statistically significant values (p < 0.05) were denoted in bold.